TSHA - Taysha Company Short-Term Debts

Corporate company logo of Taysha Corp (TSHA)

Taysha Gene Therapies (TSHA) develops treatments for rare brain pathologies, where extensive testing and technological complexity ensure long-term patent protection. Market fluctuations in the share price demonstrate the 0.00 metric, while the business remains independent of economic conditions, relying solely on regulatory verdicts. High scientific potential in Rett syndrome therapy creates a robust barrier to entry for new players.

Taysha Gene Therapies, Inc. (TSHA) - Short-Term Debt from 07/04/2022 to 11/01/2026

Analytical breakdowns for Taysha Corp (TSHA)

- share price and expert price forecast:
Stock Quotes Taysha Gene Therapies, Inc.|TSHA - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Taysha Gene Therapies, Inc.|TSHA - Enterprise Value
- business book valuation details:
Accounting Value per Share Taysha Gene Therapies|TSHA - Total Stockholders' Equity|Market Value to Book Value Ratio tayshagtx.com|TSHA - Company Total Asset Base
- debt level and financial liquidity data:
Total Debt to Capital Taysha Gene Therapies|TSHA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Taysha Gene Therapies|TSHA - Company Aggregate Debts|Debt to Book Value Taysha Gene Therapies, Inc.|TSHA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Taysha Gene Therapies|Quick Ratio tayshagtx.com
- earnings and valuation multiples indicators:
TSHA - Company Net Income
Analysis of all company metrics:Taysha Gene Therapies, Inc. - TSHA
Manufactured products of Taysha Corp

Liquidity analysis is critical for assessing the stability of the biotechnology sector. This metric measures the total volume of liabilities maturing within one year. Short-term loan debt dynamics help identify the risk of cash flow gaps when financing research and development. For Taysha Gene Therapies (TSHA), this indicator reflects the cost of maintaining target gene delivery platforms. The stability of this line confirms the company's ability to leverage tax preferences associated with orphan drug status.

Competing companies

TEM: Company Current Liabilities|Qiagen NV - Amount of Current Liabilities|IONS: Company Short-Term Debts|Repligen Inc. (RGEN) - Company Short-Term Debts|Company Current Liabilities RNA|Short-Term Debt crisprtx.com CRSP|Company Short-Term Debt GeneDx (WGS)|Short-Term Debt Volume Ultragenyx Pharmaceutical Inc.|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Company Short-Term Loans and Borrowings SRPT|Twist Bioscience - Company Short-Term Debts|TXG - Company Short-Term Debts|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|BLFS (BioLife Corp) - Company Short-Term Debts|WVE - Short-Term Indebtedness|Company Short-Term Debts MAZE|SION - Short-Term Debt|Company Short-Term Debt Prime Medicine PRME|QURE: Company Short-Term Indebtedness|MeiraGTx PLC - Company Short-Term Debts|Short-Term Debt REGENXBIO Corp|SLDB (Solid Biosciences Inc.) - Company Current Liabilities|ocugen.com - Company Short-Term Loans and Borrowings|Company Current Liabilities PACB|BNTC (Benitec Biopharma Inc) - Amount of Current Liabilities|Company Short-Term Debts DSGN|RCKT (Rocket Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts FDMT (4D Molecular Therapeutics)|Lexeo Therapeutics Inc. (LXEO) - Short-Term Debt|KRRO - Company Short-Term Debt|Company Short-Term Loans and Borrowings EDIT (Editas Medicine Inc)|SLN: Company Short-Term Debts|ProQR Therapeutics (PRQR) - Company Short-Term Debts|Company Short-Term Debt Codexis Inc|sangamo.com - Current Liabilities|Company Short-Term Debts NAUT|Short-Term Debt Volume Metagenomi Inc.|Company Short-Term Debts DTIL (Precision BioSciences)|Generation Bio Co (GBIO) - Short-Term Debt|BOLD - Company Short-Term Debt|Short-Term Debt Volume Exicure, Inc. XCUR|IMNN (imunon.com) - Company Current Liabilities|PHIO: Amount of Current Liabilities|Company Short-Term Debt Mustang Bio Inc|TransCode (RNAZ) - Short-Term Debt Volume|Company Short-Term Debts BNGO|APDN (adnas.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BLUE (bluebird bio)|Company Short-Term Debts ImmunoPrecise Antibodies Ltd IPA|Omega - Company Short-Term Debts|OMIC (Singular Genomics Corp) - Company Short-Term Indebtedness|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Debts TRACON Pharmaceuticals Inc.|Company Current Liabilities UBX (Unity Bio)